Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Program televisi dari AI: Inovasi teknologi atau degradasi seni?

● Program ‘Legenda Bertuah’ menjadi pionir tayangan televisi di Indonesia yang memanfaatkan AI secara penuh.● Penggunaan teknologi ini memicu kritik terkait potensi hilangnya k...

Bukan lagi kemanusiaan, Prabowo ingin diplomasi Indonesia fokus pada ketahanan

Presiden Prabowo Subianto dan Presiden Amerika Serikat Donald Trump di ruang konferensi di International Congress Centre, Sharm El-Sheikh, Mesir, pada Senin, 13 Oktober 2025.Muchlis Jr/Biro Pers Sekre...

Kenapa perbankan kurang berminat mendanai proyek energi terbarukan?

● Laju transisi energi nasional cenderung kurang cepat.● Hal ini disebabkan masih sulitnya pendanaan proyek-proyek energi terbarukan yang cenderung mahal.● Diperlukan promosi dan ino...